Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Current Report · Items 5.02, 7.01, 9.01 · 8-K

Aeternum Resources Inc.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Regulation FD Disclosure

Item 7.01 Regulation FD Disclosures. On August 4, 2026, the Company issued a press release regarding the employment of Josua Oosthuizen as CEO of the Company. A copy of the press release is attached as Exhibit 99.1 and is incorporated herein by reference.…

Filed Sep 1, 2026Accepted Sep 1, 2026, 10:30 AM EDTCIK 764630Accession 0001493152-26-040954
Share

Company context

Current securities

Historical securities (6)

Recent company filings

  1. 10-Q filingNov 16, 2026
  2. Entry into a Material Definitive Agreement · Unregistered Sales of Equity Securities · Regulation FD DisclosureSep 25, 2026
  3. DEF 14C filingSep 1, 2026
  4. PRE 14C filingAug 21, 2026
  5. 10-Q filingAug 19, 2026

Registered securities in this filing

AETERNUM HEALTH, INC. · 8-K · Filed 2026-09-01

As filed in this accession. Current/historical status below comes from the governed listing record; the cover itself remains exact to this filing.

Common Stock, par value $.01

Symbol
AETN
Exchange
Not supplied
Classification
COMMON
Filing context

Context: AsOf2026-07-31

Dimensions: Not supplied

Accession 000149315226040954 · 1 registered-security cover member

Read the exact SEC filing ↗

Disclosure sections

Items 5.02, 7.01, 9.01

Select an item to read the extracted section. The as-filed document remains the primary evidence.

Item 7.01Item 7.01 - Regulation FD Disclosure
Item 7.01 Regulation FD Disclosures. On August 4, 2026, the Company issued a press release regarding the employment of Josua Oosthuizen as CEO of the Company. A copy of the press release is attached as Exhibit 99.1 and is incorporated herein by reference. In accordance with General Instruction B.2 of this Current Report on Form 8-K, the information in this Item 7.01, including Exhibit 99.1, shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended, except as shall be expressly set forth by reference in such a filing. Furthermore, the furnishing of information under Item 7.01 of this Current Report on Form 8-K is not intended to constitute a determination by the Company that the information contained herein, including the exhibits hereto, is material or that the dissemination of such information is required by Regulation FD.
Filed exhibits (1)
EX-99.1 (by filename) ex99-1.htm

EX-99.1 4 ex99-1.htm EX-99.1 Exhibit 99.1 Aeternum Health Announces Change in Strategy, New Management, and Updates Investors on Progress Aeternum Health will change its name to Aeternum Resources and seeks to become a Strategic Supplier of Critical Materials. ────────────────────────────────────────────────────────────────────────────────────────────────── Appoints Paul Mann as President and Executive Chairman and Josua Oosthuizen as Chief Executive Officer. Raised over $4 million in financing to accelerate the progress on a tin and niobium mine in Nigeria, which is expected to enter commercial production during 1H 2027. Long lead-time items have been secured, access road constructed, geological surveys successfully conducted and critical infrastructure installed to accelerate initial production. CITY - August 4, 2026 - Aeternum Health (OTC: AETN) (“Company”), today announced a change in strategy, new management and provides investors with an update on corporate progress. Change in Name and Strategy The Company and its shareholders have decided to change the name and the strategic focus of the Company. The Company, which will now be called Aeternum…

Open exhibit ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.